Calabra's Talking Biotech Podcast

This is Calabra's talking biotech podcast and we'll be back in just a moment. We're speaking with Betsy O'Neill, the VP of external innovation at Horizon Therapeutics. She talks about what her company does in the area of new drug design for autoimmune and rare diseases. And on the backside of the break, we'll talk about the new innovations that are actually hitting the ground and the pipeline of things to expect.